COVID-19

In the past week, Moderna and AstraZeneca have collectively announced multiple authorizations for use of their respective vaccines.

Despite the concerns that may come along with mutations of the SARS-CoV-2 virus, experts say the new strains do not call for any new prevention strategies.

In a recent study at the National Institutes of Health, researchers consistently observed signs of damage on the brain scans of patients who died after contracting COVID-19.

Pralatrexate, a lymphoma drug, outperformed remdesivir in treating COVID-19 in a lab experiment.

The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.

Socioeconomic and racial health disparities contribute to worse cancer and COVID-19 outcomes.

A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.

The company began administering COVID-19 vaccines to residents and staff at long-term care facilities in late December as part of the CDC Pharmacy Partnership for Long-term Care Program.

Despite fringe conspiracy theories that circulated online, COVID-19 carries a greater risk of health problems than the flu.

The event focused on the care, compassion, and connections the are important to pharmacists, and how the profession can tackle challenges such as payment reform and public awareness.

Soon, all Americans will be able to receive the vaccine at pharmacies including CVS and Walgreens, and their primary care provider's office.

Reports indicate a mortality rate of up to 28% among solid organ transplant patients hospitalized with coronavirus disease 2019.

The organization’s public statement comes after a pharmacist was arrested for destroying over 500 doses.

Pharmacy students, particularly the graduating class of 2020, have been uniquely affected by the coronavirus disease 2019 (COVID-19) pandemic.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

Randall A. Oyer, MD, discusses rising cancer mortality during the coronavirus disease 2019 (COVID-19) pandemic and what that means for cancer care.

Pfizer and BioNTech, and Moderna have announced agreements to further supply vaccines against the coronavirus disease 2019 (COVID-19).

Telehealth has been crucial in expanding access to naloxone, a lifesaving drug used to reverse the effects of an opioid overdose.

According to AstraZeneca, the company is currently conducting a large trial in the US and in other countries around the world.

Deferred care can result in worse outcomes, advanced complications, or earlier death for many patients with cancer, heart disease, and other serious illnesses.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about recommended plans and advice for those who are struggling with addiction during the holidays and the COVID-19 pandemic.

Pharmacy Times spoke with Jeremy Barnett, LMHC, CASAC & Expert at Help.org, about substance abuse dangers during COVID-19 and the holiday season.

Earlier this month, the Canadian government also exercised its option to increase its confirmed order commitment of mRNA-1273.

This agreement brings the total number to be delivered to the United States to 200 million.

In CNN's recent Sesame Street ABC's of COVID-19 town hall, Anthony Fauci, MD, answered questions addressing children’s concerns for Santa’s health during the COVID-19 pandemic.

A history of hypertension was found to increase the risk of acute kidney injury 5-fold, study results showed.

The kit will be shipped overnight to the customer’s home, where they can self-administer the test collection using a short nasal swab and send their sample back to Labcorp.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for managing the waiting period in the pharmacy following COVID-19 immunizations.

Pharmacy Times® interviewed Michael Flannery, PharmD, the assistant director of pharmacy operations at the University of Rochester Medical Center, on the process for immunizing staff at a hospital pharmacy with the COVID-19 vaccines.

Emphasizing the importance of the COVID-19 vaccine to younger generations and those with no underlying health conditions could significantly increase the overall rate of vaccination in the United States.